Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap FiercePharma 13:41 Fri, 29 May
Astellas To Drive Strategic Brands, Pivotal Studies To Fill Xtandi Gap Scrip Pharma Intelligence 07:45 Wed, 27 May
Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company Astellas Pharma (Press Release) 07:33 Tue, 26 May
Assessing Vir Biotechnology (VIR) Valuation After Hepatitis Delta Data Update And Astellas Oncology Partnership Simply Wall St 01:25 Mon, 25 May
Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026 PR Newswire (Press Release) 13:05 Mon, 18 May
Notice Regarding Continuation of the Performance-linked Stock Compensation Scheme and Performance-linked Stock Delivery Scheme for the Domestic and Global Astellas Group Executives Astellas Pharma (Press Release) 03:32 Fri, 15 May
Astellas Submits Supplemental New Drug Application in Japan for PADCEV™ (enfortumab vedotin) plus Keytruda® (pembrolizumab) in Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer Astellas Pharma (Press Release) 07:00 Thu, 14 May
Greenvolt Next completes 2.2MW PV plant at Astellas Damastown facility in Dublin Solar Power Portal 10:23 Tue, 12 May
STAT Plus: Astellas treatment offers new hope to a devastated rare disease community STAT 15:50 Mon, 11 May
Greenvolt Next installs 2.2-MWp solar farm for Astellas Pharma in Dublin RenewablesNow.com 16:20 Thu, 07 May
Greenvolt Next deliver 2.2MWp solar farm for Astellas in four months Business Plus Online 16:14 Wed, 06 May
